FarmaMondo Group is a Swiss-based global commercialization partner helping biopharma innovators expand patient access in emerging markets. We specialize in rare, specialty, and complex therapies, offering both managed access and full registration commercialization solutions. Through a single Swiss entity and on-the-ground operations across Latin America, Asia Pacific, India & South Asia, MENA & Turkey, Russia & CIS, and the Nordics/Baltics, FarmaMondo provides compliant, agile routes to market. Our mission is simple: to ensure geography is never a barrier to care—connecting life-changing therapies with patients who need them most.